Osaic Holdings’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.3K Sell
860
-664
-44% -$19.6K ﹤0.01% 5924
2026
Q1
$45.9K Buy
1,524
+123
+9% +$3.98K ﹤0.01% 5290
2025
Q4
$48.6K Sell
1,401
-1,894
-57% -$66.9K ﹤0.01% 5253
2025
Q3
$114K Buy
3,295
+147
+5% +$4.99K ﹤0.01% 4668
2025
Q2
$96.5K Buy
3,148
+1,700
+117% +$52.8K ﹤0.01% 4529
2025
Q1
$43K Sell
1,448
-257
-15% -$7.71K ﹤0.01% 4835
2024
Q4
$50.3K Buy
1,705
+328
+24% +$10.4K ﹤0.01% 4699
2024
Q3
$42.9K Buy
1,377
+306
+29% +$11.1K ﹤0.01% 4856
2024
Q2
$36.3K Sell
1,071
-114
-10% -$5.81K ﹤0.01% 4931
2024
Q1
$77K Sell
1,185
-1,495
-56% -$103K ﹤0.01% 4428
2023
Q4
$183K Sell
2,680
-83
-3% -$4.31K ﹤0.01% 3993
2023
Q3
$143K Buy
2,763
+817
+42% +$48.4K ﹤0.01% 4231
2023
Q2
$117K Buy
1,946
+1,197
+160% +$68.3K ﹤0.01% 4312
2023
Q1
$37K Buy
749
+20
+3% +$1.13K ﹤0.01% 5166
2022
Q4
$41K Buy
729
+11
+2% +$619 ﹤0.01% 5074
2022
Q3
$33K Buy
718
+134
+23% +$6.39K ﹤0.01% 5235
2022
Q2
$21K Hold
584
﹤0.01% 5576
2022
Q1
$17K Buy
584
+440
+306% +$11.1K ﹤0.01% 5810
2021
Q4
$5K Buy
144
+21
+17% +$760 ﹤0.01% 6629
2021
Q3
$4K Sell
123
-6
-5% -$203 ﹤0.01% 6629
2021
Q2
$5K Buy
129
+7
+6% +$270 ﹤0.01% 6365
2021
Q1
$5K Buy
+122
New +$5.43K ﹤0.01% 6151

Other funds holding IMCR

Osaic Holdings's IMCR Position: Q2 2026 in Review

Osaic Holdings reduced its Immunocore (IMCR) stake by 44% in Q2 2026, selling an estimated $19.6K and leaving 860 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5924.

Osaic Holdings first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $183K in Q4 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Osaic Holdings held 860 shares of Immunocore worth $27.3K as of Q2 2026.
  • Osaic Holdings sold 664 Immunocore shares in Q2 2026, an estimated $19.6K.
  • Immunocore made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5924 holding.
  • Osaic Holdings first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • Osaic Holdings's Immunocore position peaked at $183K in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.